About the Authors
- Philipp Cedro
-
Roles Conceptualization, Investigation, Methodology, Resources, Writing – original draft
* E-mail: philipp.cedro@roche.com
Affiliation Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland
- Roman Popov
-
Roles Methodology, Writing – review & editing
Affiliation Lino Biotech Ltd., Adliswil, Switzerland
- Maxime Karrer
-
Roles Methodology, Resources
Affiliation Roche Pharma Research and Early Development, DTA Oncology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland
- Jean-Christophe Hau
-
Roles Methodology, Writing – review & editing
Affiliation Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland
- Eric-André Kusznir
-
Roles Investigation
Affiliation Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland
- Ralf Thoma
-
Roles Resources
Affiliation Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland
- Andreas Frutiger
-
Roles Methodology, Software, Writing – review & editing
Affiliation Lino Biotech Ltd., Adliswil, Switzerland
- Matthias Lauer
-
Roles Conceptualization, Project administration, Writing – review & editing
Affiliation Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland
- Sylwia Huber
-
Roles Conceptualization, Methodology, Project administration, Supervision, Writing – review & editing
Affiliation Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland
Competing Interests
The following authors declare conflict of interests: Andreas Frutiger and Roman Popov are employed by Lino Biotech AG and are providers of Focal Molography technology. The study was conceptualized by Roche employees and performed on Roche premises. The published data are owned by Roche. The manuscript was written by Roche employees with input from Andreas Frutiger and Roman Popov. Data analysis was performed by Philipp Cedro, Sylwia Huber in collaboration with Andreas Frutiger and Roman Popov.